The insulin dosage market size value per capita in Croatia showed a fluctuating trend from 2013 to 2023. Starting at $17.09 in 2013, it grew steadily until peaking at $22.72 in 2021, before retracting to $21.13 in 2023. Notable fluctuations include an 18.83% increase from 2017 to 2018 and a sharp decline in 2022. Over the last two years (2022-2023), the market experienced a marginal recovery with a year-on-year increase of 1.1%. The compound annual growth rate (CAGR) from 2018 to 2023 averaged 0.3%.
Future trends to watch for include potential impacts from healthcare policy changes, advancements in insulin delivery technology, and the prevalence of diabetes in the Croatian population, which could influence market dynamics significantly.
| # | 22 Countries | US Dollars Per Capita | Last Year | |||
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 29.7 | 2023 | View data | ||
| 2 | 2 United Kingdom | 27.44 | 2023 | View data | ||
| 3 | 3 Greece | 26.06 | 2023 | View data | ||
| 4 | 4 Netherlands | 24.72 | 2023 | View data | ||
| 5 | 5 Belgium | 21.98 | 2023 | View data | ||
| 6 | 6 Australia | 21.27 | 2023 | View data | ||
| 7 | 7 Croatia | 21.13 | 2023 | |||
| 8 | 8 Italy | 20.63 | 2023 | View data | ||
| 9 | 9 Sweden | 19.49 | 2023 | View data | ||
